Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Capital Leases (2023 - 2025)

Cresco Labs (CRLBF) has disclosed Capital Leases for 2 consecutive years, with $20.6 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Capital Leases fell 7.86% year-over-year to $20.6 million, compared with a TTM value of $20.6 million through Dec 2024, down 7.86%, and an annual FY2024 reading of $20.6 million, down 7.86% over the prior year.
  • Capital Leases was $20.6 million for Q4 2024 at Cresco Labs, down from $22.4 million in the prior quarter.
  • Across five years, Capital Leases topped out at $22.4 million in Q4 2023 and bottomed at $20.6 million in Q4 2024.